Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-Cβ-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability
Authors:
- Khurrum ShahzadKSKhurrum Shahzad
- Muhammed KashifMKMuhammed Kashif
- Ilya A. VinnikovIVIlya A. Vinnikov
- Martin SchillerMSMartin Schiller
- Hongjie WangHWHongjie Wang
- Thati MadhusudhanTMThati Madhusudhan
- Volker EcksteinVEVolker Eckstein
- Angelika BierhausABAngelika Bierhaus
- Florian BeaFBFlorian Bea
- Erwin BlessingEBErwin Blessing
- Hartmut WeilerHWHartmut Weiler
- 1 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (9) , 774-784
Abstract
Background— Clinical studies failed to provide clear evidence for a proatherogenic role of hypercoagulability. This is in contrast to the well-established detrimental role of hypercoagulability and thrombin during acute atherosclerotic complications. These seemingly opposing data suggest that hypercoagulability might exert both proatherogenic and antiatherogenic effects. We therefore investigated whether hypercoagulability mediates a beneficial effect during de novo atherogenesis. Methods and Results— De novo atherogenesis was evaluated in 2 mouse models with hyperlipidemia and genetically imposed hypercoagulability (TM Pro/Pro ApoE −/− and FVL Q/Q ApoE −/− mice). In both mouse models, hypercoagulability resulted in larger plaques, but vascular stenosis was not enhanced secondary to positive vascular remodeling. Importantly, plaque stability was increased in hypercoagulable mice with less necrotic cores, more extracellular matrix, more smooth muscle cells, and fewer macrophages. Long-term anticoagulation reversed these changes. The reduced frequency of intraplaque macrophages in hypercoagulable mice is explained by an inhibitory role of thrombin and protease-activated receptor-1 on monocyte transendothelial migration in vitro. This is dependent on phospholipase-Cβ, phosphoinositide 3-kinase, and nitric oxide signaling in monocytes but not in endothelial cells. Conclusions— Here, we show a new function of the coagulation system, averting stenosis and plaque destabilization during de novo atherogenesis. The in vivo and in vitro data establish that thrombin-induced signaling via protease-activated receptor-1, phospholipase-Cβ, phosphoinositide 3-kinase, and nitric oxide in monocytes impairs monocyte transendothelial migration. This likely accounts for the reduced macrophage accumulation in plaques of hypercoagulable mice. Thus, in contrast to their role in unstable plaques or after vascular injury, hypercoagulability and thrombin convey a protective effect during de novo atherogenesis.Keywords
This publication has 42 references indexed in Scilit:
- Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivoJournal of Experimental Medicine, 2008
- The Roles of Proteinase-Activated Receptors in the Vascular Physiology and PathophysiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytesJournal of Leukocyte Biology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in MiceCirculation, 2005
- No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factorsJournal of Thrombosis and Haemostasis, 2004
- Inflammation in atherosclerosisNature, 2002
- Thrombin Upregulates Tissue Transglutaminase in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary AtherosclerosisThe American Journal of Pathology, 2001
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987